Navigation Links
New, Larger, Bilateral Breast Graft Kits Announced by MTF
Date:1/4/2012

EDISON, N.J., Jan. 4, 2012 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has announced the release of two new sizes of its popular FLEX HD® bi-lateral breast kits. The new sizes--16cm x 20cm and 20cm x 20cm--are being introduced in order to meet the needs of surgeons and their patients. This unique human dermal allograft is specifically prepared and packaged for bilateral breast reconstruction.

It has been a year since MTF introduced its bi-lateral breast kit for the first time.  The new, larger sizes are being released based on surgeon input to accommodate the need for larger tissue coverage that may be called for depending on implant and patient considerations. 

The use of human acellular dermal matrix (ADM) grafts in breast reconstruction is becoming increasingly popular.  Since many breast cases are bilateral, and aesthetic outcomes are desired, surgeons asked MTF for procedure-based kits containing two matched pieces of FlexHD acellular hydrated dermal tissue, prepared from the same donor.

FlexHD grafts offer excellent handling characteristics and biomechanical properties as well as the added benefit of convenience.  They are packaged hydrated and do not require hydration prior to use or refrigeration for storage, resulting in tissue grafts that are easily accessible and ready to use at all times.

FlexHD grafts help to avoid potentially costly and unnecessary work prior to and during cases.  Surgeons may select the size and type of graft they'd like to use any time during a procedure, preventing any of the costs associated with wasted tissue or added OR time.

FlexHD passes USP <71> sterility tests and meets or exceeds FDA and AATB standards for donor criteria, processing and tissue safety. With over 4.8 million grafts distributed since its inception, MTF possesses an unrivaled safety record.

To inquire about these new breast kits contact MTF customer service at 1-800-433-6576.

The Musculoskeletal Transplant Foundation, a non-profit organization, is the nation's leading tissue bank. The Foundation is a national consortium comprised of leading academic medical institutions, organ procurement organizations and tissue recovery organizations.  Since its inception in 1987, MTF has received tissue from close to 90,000 donors and distributed almost five million grafts for transplantation.

For information:
Cindy Gordon, Insight Communication
609.252.1300


'/>"/>
SOURCE The Musculoskeletal Transplant Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bilateral DePuy Hip Implant Failures Lead to Lawsuit
2. Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television
3. Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
4. Diablo Valley Oncology Performs Breast Intraoperative Radiation Procedure - First in the East Bay
5. Use of MarginProbe® in DCIS Patients Presented at San Antonio Breast Cancer Symposium
6. Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
7. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
8. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
9. MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium
10. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
11. Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... -- According to a new market research report "Clinical Decision ... Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - ... reach USD 1,519.2 Million by 2021 from USD 856.3 Million in 2016, ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... Dec. 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... company focused on delivering scientific and medical breakthroughs ... Chairman and Chief Executive Officer Keith Murphy ... Wednesday, December 14, 2016 at 1:00 p.m. Eastern ... not yet familiar with the Company, an informational ...
(Date:12/7/2016)... According to the latest market ... Study on Multiplex Detection Immunoassay: North America to Dominate ... detection immunoassay market is expected to witness a CAGR of ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 ... ... A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... dogs. The study was published in the prestigious Journal of Veterinary Science & ...
(Date:12/7/2016)... ... ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday Deals On ... 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 , Delete® - ... on Botox® and Juvederm® just in time for the holiday party season. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors ... said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 ... drop zones. Editors can select from a variety of flip book animations. In Addition, ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... individuals impacted by cerebral cavernous angiomas, was awarded a grant from the Julian ... engagement program. New Mexico has more people with cavernous angioma than anywhere in ...
Breaking Medicine News(10 mins):